胞性線維症:二酸化炭素分泌の障害と粘液胞症
1Department of Pediatrics, University of California, San Diego School of Medicine, and Biomedical Sciences, University of California, Riverside (UCR), La Jolla, CA 92093, USA. pquinton@ucsd.edu
Lancet (London, England)
|August 5, 2008
まとめ
胞性線維症の粘液濃縮は,塩化物チャネルの問題だけでなく,バイカーボネート輸送の欠陥から生じる可能性があります. これはムシンの膨張と輸送に影響を及ぼし,病気の病原性における二重の役割を示唆しています.
科学分野:
- バイオケミストリー バイオケミストリー
- 生理学 生理学とは
- 遺伝学 遺伝学とは
背景:
- 胞性線維症は,異常な厚さのある粘液 (粘液胞症) が特徴です.
- これは,システィック線維症のトランスメブラン伝導性調節器 (CFTR) クロライドチャネルの遺伝的欠陥と関連付けられています.
- 現在の理論では,脱水の原因は,塩化物に依存した流体輸送の欠陥があると考えられていますが,これは生理学的に矛盾しています.
研究 の 目的:
- 性線維症の病原性に関する新しい仮説を提案する.
- 粘液の膨張と粘液形成における二酸化炭素 (HCO3-) 輸送の役割を調査する.
- 性線維症の説明において,塩化物輸送欠陥にのみ依存していることに異議を唱える.
主な方法:
- システィック線維症に関する既存の生理学的および遺伝的データのレビュー.
- ムシンの粒子の放出と膨張のメカニズムの分析.
- ミューシン溶解化のためのカチオン複合化におけるバイカーボネートの役割を仮説化する.
主要な成果:
- ムシンの膨張には,Ca (−2+) とH (−+) カチオンの除去が必要です.
- ビカルボネート (HCO3-) は,これらのカチオンと複合体を形成することによって,正常なムシンの膨張に不可欠です.
- 性線維症におけるHCO3の欠陥分泌は,不十分な膨張,集積された粘膜につながる.
結論:
- 胞性線維症の病原性には,塩化物輸送と同様に,バイカーボネート輸送の欠陥が含まれる可能性があります.
- HCO3欠陥によるムシンの膨張と溶解の障害は,疾患に寄与する.
- この仮説は,システィック線維症の病理生理学に関する新しい視点を提供します.
関連する概念動画
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.